The search of DNAintercalators as antitumoral drugs: What it worked and what did not work
Martínez R and Chacón-García L. The search of DNAintercalators as antitumoral drugs: what it worked and what did not work. Curr. Med. Chem. (2005) 12: 127-151.
Gnidilatimonoein from Daphne mucronata inhibits DNA synthesis in human cancer cell lines
78-78
Sadeghi H and Yazdanparast R. Gnidilatimonoein from Daphne mucronata inhibits DNA synthesis in human cancer cell lines. Iranian J. Pharm. Res. (2004) Suppl 2:78-78.
DNA as a target for anticancer compounds: Methods to determine the mode of binding and the mechanism of action
Palchaudhuri R and Hergenrother PJ. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotech. (2007) 18: 497-503.
Intercalating and antitumour activity of 4-oxopyrimido [4′, 5′:4, 5] thieno(2, 3-b)quinoline-4 (3H)-one
Shahabuddin MS, Gopal M and Raghavan SC. Intercalating and antitumour activity of 4-oxopyrimido [4′, 5′:4, 5] thieno(2, 3-b)quinoline-4 (3H)-one. J. Cancer Mol. (2007) 3: 139-146.
Effect of modification of 6-[(aminoalkyl)amino]-7H-benzo[e]-perimidin-7-ones on their cytotoxic activity toward sensitive and multidrug resistant tumor cell lines. Synthesis and biological evaluation
Dzieduszycka M, Martelli S, Arciemiuk M, Bontemps-Gracz MM, Kupiec A and Borowski E. Effect of modification of 6-[(aminoalkyl)amino]-7H-benzo[e]-perimidin-7-ones on their cytotoxic activity toward sensitive and multidrug resistant tumor cell lines. Synthesis and biological evaluation. Bioorg. Med. Chem. (2002) 10: 1025-1035.
Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA
Baginski M, Fogolari F and Briggs JM. Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA. J. Mol. Biol. (1997) 274: 253-67.
Nandeeshaiah SK and Ambeker SY. Synthesis of 2-aryl-1, 2, 3, 4-tetrahydropyrido [2′, 3′:4, 5] thieno [2, 3-b]quinolin-4-ones. Indian J. Chem. (1994) 33: 375-379.
Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives
Miri R, Javidnia K, Hemmateenejad B, Azarpira A and Amirghofran Z. Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives. Bioorg. Med. Chem. (2004) 12: 2529-2536.
Synthesis, cytotoxicity, DNA interaction and topoisomerase II inhibition properties of tetrahydropyrrolo[3, 4-a] carbazole-1, 3-dione and tetrahydropyrido-[3, 2-b] pyrrolo[3, 4-g]indole-1, 3-dione derivatives
Joseph B, Facompre M, Da Costa H, Routier S, Merour JY, Colson P, Houssier C and Bailly C. Synthesis, cytotoxicity, DNA interaction and topoisomerase II inhibition properties of tetrahydropyrrolo[3, 4-a] carbazole-1, 3-dione and tetrahydropyrido-[3, 2-b] pyrrolo[3, 4-g]indole-1, 3-dione derivatives. Bioorg. Med. Chem. (2001) 9: 1533-41.
Synthesis and structure-activity relationship of methyl-substituted indolo[2, 3-b] quinolines: Novel cytotoxic, DNA topoisomerase II inhibitors
Peczynska-Czoch W, Pognan F, Kaczmarek L and Boratynski J. Synthesis and structure-activity relationship of methyl-substituted indolo[2, 3-b] quinolines: novel cytotoxic, DNA topoisomerase II inhibitors. J. Med. Chem. (1994) 7: 3503-3510.
Ring-substituted 11-oxo-11H-indeno [1, 2-b] quinoline-6-carboxamides with similar patterns of cytotoxicity to the dual topo I/II inhibitor DACA
Deady LW, Desneves J, Kaye AJ, Thompson M, Finlay GJ, Baguley BC and Denny WA. Ring-substituted 11-oxo-11H-indeno [1, 2-b] quinoline-6-carboxamides with similar patterns of cytotoxicity to the dual topo I/II inhibitor DACA. Bioorg. Med. Chem. (1999) 7: 2801-2809.
Dihydropyridine derivatives to overcome atypical multidrug resistance: Design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities
Mehdipour AR, Javidnia K, Hemmateenejad B, Amirghofran Z and Miri R. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities. Chem. Biol. Drug. Des. (2007) 70: 337-346.
